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We characterized themetabolic profile of transgenicmice exhibiting enhancedmuscle mass driven by increasedmIGF-1 expression
(MLC/mIGF-1). As expected, 6-month-old MLC/mIGF-1 mice were heavier than age-matched wild type (WT) mice (37.4 ± 0.3
versus 31.8 ± 0.6 g, resp.). MLC/mIGF-1 mice had higher respiratory quotient when compared toWT (0.9 ± 0.03 versus 0.74 ± 0.02,
resp.) suggesting a preference for carbohydrate as the major fuel source. MLC/mIGF-1 mice had a higher rate of glucose disposal
when compared to WT (3.25 ± 0.14 versus 2.39 ± 0.03%/min, resp.). The higher disposal rate correlated to ∼2-fold higher GLUT4
content in the extensor digitorum longus (EDL) muscle. Analysis of mRNA content for the glycolysis-related gene PFK-1 showed
∼3-fold upregulation in MLC/mIGF-1 animals. We also found a 50% downregulation of PGC1𝛼 mRNA levels in MLC/mIGF-1
mouse EDL muscle, suggesting less abundant mitochondria in this tissue. We found no difference in the expression of PPAR𝛼 and
PPAR𝛽/𝛿, suggesting no modulation of key elements in oxidative metabolism. These data together suggest a shift in metabolism
towards higher carbohydrate utilization, and that could explain the increased insulin sensitivity of hypertrophied skeletal muscle
in MLC/mIGF-1 mice.
1. Introduction
One of the remarkable features of skeletal muscle is the
capacity to adapt its metabolic and functional properties in
response to a wide range of external factors, including physi-
cal andneuron activity, change in hormone levels, and oxygen
and nutrient supply [1]. However in several pathological
conditions, skeletal muscle severely decreases this adaptive
capacity, triggering alterations in its metabolic properties
evolving to disease. In fact, insulin resistance (IR), obesity,
high blood pressure, high fasting glucose or hyperglycemia,
and lipid abnormalities are all conditions related to morpho-
functional and metabolic changes in skeletal muscle [2].
Recent evidences have shown that different therapeutic
interventions can improve body composition and systemic
metabolism [3]. Among these, physical activity has been con-
sidered in the therapeutic effects of exercise for type II dia-
betes (T2DM) and other metabolic syndromes [4], although
regular physical activity as a therapeutic tool can be seriously
assumed in only a fraction of the population, mainly due
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to motivational and physical limitations. From a metabolic
point of view, however, it remains not well understood what
molecular/cellular aspects of exercise should be mimicked
and what type of muscle fiber is best targeted to improve
metabolic dysfunction. Increased physical activity is usually
achieved by exercise training, which can be divided into two
major categories: endurance and resistance. It is well known
that endurance training promotes metabolic alterations in
skeletal muscle due to a shift in substrate preference as a
consequence of fatty acid oxidative metabolism and muscle
fiber type interconversion, resulting in a greater number of
the slow twitch oxidative fibers [5]. In contrast, resistance
training is known for its capacity to promote an increase
in skeletal muscle mass (hypertrophy) and strength [6].
Nonetheless, the molecular factors linking skeletal muscle
growth and metabolism still remain to be explored in detail.
Among growth factors, the Insulin-like growth factor-1 (IGF-
1) has been implicated in the control of bothmuscle mass and
skeletal muscle homeostasis and its expression is significantly
enhanced in response to exercise [7].
It has been previously reported that muscle restricted
mIGF-1 transgene (MLC/mIGF-1) sustains muscle hypertro-
phy and regeneration in senescent skeletal muscle, enhances
the recruitment of circulating stem cells in injured muscle
[8], and counteracts muscle wasting in mdx dystrophic
mice [9], improving muscle mass and strength and elevating
pathways associated with muscle survival and regeneration.
Although significant advances have been made with this
genetic model, overall, the impact of manipulating skeletal
muscle hypertrophic pathways upon whole bodymetabolism
and glucose disposal is largely unknown.
In the present study, we investigatedmetabolic features of
MLC/mIGF-1 mice, revealing an unexpected higher respira-
tory quotient at rest, an index of higher carbohydrate utiliza-
tion. These animals also showed higher insulin sensitivity, in
line with a preference for carbohydrate as the primary energy
source. In addition we have detected increased GLUT4
protein levels in skeletal muscle. These findings reinforce
the potential of manipulating IGF-1 triggered intracellular
pathways as therapeutic tools in the treatment of insulin
resistance and type II diabetes.
2. Research Design and Methods
2.1. Animals. All procedures described were performed in
accordance with the guidelines of the committee on animal
research at the Institute of Biomedical Sciences, University
of Sa˜o Paulo. Animals aged 4–6 months were obtained from
our colony at the Department of Anatomy animal facility.
Mice were housed at 21∘C on a 12 h dark/light cycle (lights
on 18:00 to 06:00 h) with free access to food and water. At
the end of the experiments, animals were anesthetized with
a ketamine/xylazine combination (100mg/kg and 10mg/kg
b.w., resp.), tissues were harvested and euthanasia performed
by exsanguination cardiac arrest. Our MLC/mIGF-1 mice
inbred colony was expanded from two heterozygote males
donated by Dr. Musaro` [8].
2.2. Genotyping. Approximately 0.5 cm of mouse tail tip was
excised and submitted to total DNA extraction according
to a protocol previously described [10], with the follow-
ing modifications; tail biopsies were digested overnight at
55∘C with agitation in lysis buffer (100mM Tris-HCl pH
8.5, 10mM EDTA pH 8.0, 0.5% SDS, and 200mM NaCl)
supplemented with 10 𝜇g Proteinase K (Invitrogen, Carlsbad,
CA, USA). The resulting material was precipitated with
isopropanol, washed in 70% ethanolandre-suspended in TE
pH 8.0. Eighty nanograms of total genomic DNA was then
submitted to conventional PCR.The reaction was carried out
using a common sense primer targeting both mouse and rat
MLC promoters (5󸀠-GTGTCAAGGTTCTATTAGGCACTA-
3󸀠), and the presence of the transgenic gene was detected
using a specific antisense primer targeting the mIGF-1 con-
struct (5󸀠-GAGCTGACTTTGTAGGCTTCA-3󸀠); a positive
control reaction was performed using a specific primer (5󸀠-
TGACCAAAACGATTCACCTG-3󸀠) targeting the mouse
MLC gene. Cycling conditions were 3min at 95∘C “hot start”,
followed by 35 cycles at 95∘C for 25 s, 60∘C for 30 s, and
72∘C for 60 s. The control amplicon consisted of ∼300 bp
fragment and the presence of the transgene was confirmed
by identification of ∼600 bp fragment, as determined by
electrophoretic analysis.
2.3. Muscle Mass Determination, Histochemical Analysis, and
Measurement of Cross-Sectional Area. At the time of animal
sacrifice, soleus and extensor digitorum longus (EDL) mus-
cles were carefully dissected from both limbs. The muscle
was weighted and cut in half; one segment was immersed
in cold isopentane for 30 seconds, cooled in liquid nitrogen,
and stored at −80∘C for histochemistry; the other segment
was snap frozen in liquid nitrogen and stored at −80∘C for
later analysis. EDL and soleus frozenmuscles were cut into 10
𝜇m cross-sections on a cryostat (CM3050; Leica, Nussloch,
Germany) in order to determine the CSA of different fiber
types by myofibrillar ATPase activity after alkaline (ATPase,
pH 10.3) or acid preincubation (ATPase, pH 4.1) [11, 12]. The
CSA (cross-sectional area) and relative total composition of
each fiber type were obtained by measuring the CSAs of
approximately 500 muscle fibers of each mouse (expressed as
mean ± SEM) through image software Image Pro-Plus. The
acquisition of the images was realized using a microscope
(Nikon Eclipse TS100, Japan) equipped with a digital video
camera and imaging software (NIS-Elements BR).
2.4. Fasting Blood Cholesterol, Triglycerides and Glucose Con-
centrations, and Carcass Lipid Content. Animals were fasted
for 8 h, with food being removed at 08:00 h and the test
begun at 16:00 h. Cholesterol and triglycerides were deter-
mined in spectrophotometer by colorimetric method using
a commercial KIT (Labtest Diagno´stica S/A, Lagoa Santa,
MG, Brazil). Glucose was determined using specific test
strips in an Accu-Chek meter (Roche Diagnostics GmbH,
Mannheim, Germany). For carcass analysis, lipid extraction
was performed as described [13] and body fat percentage was
determined.
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2.5. Oxygen Consumption. Resting metabolic rate was esti-
mated by determining oxygen consumption (VO
2
) in an open
circuit respirometer (O2-10, Sable System, Las Vegas, NV,
USA) [14, 15]. The measurements were conducted always in
the afternoon (14:00–18:00 h) for 30min at 25∘C in animals
fed ad libitum.The data were collected and evaluated by using
the Sable Systems software. The results were expressed as
milliliters of O
2
/min/grams of BW [16, 17].
2.6. Insulin Tolerance Test (ITT) and kITT Determination.
For ITT, animals were deprived of food for 2 h. Standard
insulin diluted in saline was injected (0.125U/kg) via the
caudal vein. Blood glucose was measured with a glucometer
(Accu-chek, Roche) at 0, 6, 9, 12, and 15 minutes after insulin
injection. The constant rate for blood glucose disappearance
(kITT) was calculated based on the linear regression of the
Napierian logarithm of blood glucose concentrations [18].
2.7. Real-TimeQuantitative Polymerase ChainReaction. Real-
time quantitative polymerase chain reaction (PCR) was
performed on an ABI Prism 5700 sequence detection system
(Applied Biosystems, Foster City, CA, USA) using SYBR
Green (Applied Biosystems) following the instructions pro-
vided by the manufacturer. Thermal-cycling conditions for
the real-time PCR were 50∘C for 2min, 95∘C for 10min, and
then 40 cycles of 95∘C for 15 s, 60∘C for 25 s, and 72∘C for 30 s.
The internal control, Cyclophilin A (CycloA), was amplified
in separate tubes. The data were collected semiquantitatively
together with the cycle threshold reading of corresponding
CycloA internal controls.Data fromfive to six determinations
(mean ± SEM) are expressed in all experiments as fold
changes relative to the control group which was arbitrarily set
as one. Primers are available upon request.
2.8. Western-Blot Analysis. Protein extracts from tissue sam-
ples were obtained by ultrasonic membrane disruption in
lysis buffer, containing Tris-HCl (pH 7.5) 100mM, EDTA
10mM, SDS 1%, NaF 100mM, Na
4
PO
2
O
7
10mM, and
sodium orthovanadate 10mM, supplemented with protease
inhibitor (Sigma). Protein concentration was determined
by the Bradford method [19]. Fifty micrograms of total
protein was loaded on a 12% SDS:acrylamide gel (SDS-
PAGE) and separated by electrophoresis. Proteins were trans-
ferred to a nitrocellulose membrane in a semidry system
and probed using a specific antibody for GLUT4 (1 : 1000;
cat#2213; Cell Signaling) or GAPDH (1 : 1000; cat#2118; Cell
Signaling) with incubation overnight at 4∘C. Membrane was
washed 15min in TBS-T (Tween Tris-buffered saline solu-
tion) and incubated with secondary antibody goat anti-rabbit
IgG (alkaline-phosphatase conjugated 1 : 1000; cat#D0487;
Dako©, Glostrup, Denmark) for 1 hour at room temperature
and posteriorly washed again for 15min in TBS-T. Specific
bands were visualized by enzymatic colorimetric NBT/BCIP
(Roche, Mannheim, Germany).
2.9. Data Analysis. All data obtained were analyzed using
GraphPad Prism version 5.00.288 (GraphPad Software Inc.
San Diego, CA, USA) and plotted as graphs. Data were sub-
mitted to Student’s 𝑡-test to compare WT and MLC/mIGF-1
animals. All data are expressed as mean ± SEM.
3. Results
As expected,MLC/mIGF-1mice [8] presented a very selective
and marked hypertrophy in the EDL muscle, which predom-
inantly contains type II fast twitch fibers. This is supported
by the 1.47-fold increment in wet weight in MLC/mIGF-
1 EDL muscle (Figure 1(a)); on the other hand, no change
in soleus wet weight was observed. Histochemical analysis
clearly demonstrated an increase in incidence of fiber type IIb
and decrease in the incidence of fiber type IIa/IId in the EDL
of MLC/mIGF-1 animals when compared to WT animals
(Figure 1(b)); on the other hand, the predominance of fiber
types in the soleus muscle did not change (Figure 1(b)). We
found that CSA of fiber types IIa/IId and IIb are increased
in EDL muscle of MLC/mIGF-1 (Figures 1(c) and 1(d)) mice.
Curiously, CSA of type IC/IIC and IIa fibers decreased in
soleus muscle as compared to WT animals (Figures 1(c) and
1(d)). Because we have found increases in wet weight and
CSA only in the EDL, we decided to proceed with further
measurements exclusively in this muscle.
Analysis of biometric parameters of MLC/mIGF-1 mice
revealed a very significant increase in body weight (37.4±0.3
versus 31.8 ± 0.6 g, 𝑃 < 0.0001, MLC/mIGF-1 and WT,
resp., Table 1). This appears to be a major consequence
of skeletal muscle hypertrophy, since there were no dif-
ferences in fat mass and body fat composition (Table 1).
Also, although MLC/mIGF-1 animals were heavier we did
not find a difference in length between the two groups
(Table 1). It was intuitive to assume that MLC/mIGF-1 mice
would sustain greater skeletal muscle mass at the expense
of higher food consumption. Nevertheless, we observed the
same food intake per animal (not shown) in both groups and,
more interestingly, lower food consumption in MLC/mIGF-
1 mice compared to WT when corrected for body weight
(Table 1). Because these data suggested increased metabolic
efficiency in the MLC/mIGF-1 model, we decided to test
this hypothesis by indirect calorimetry. Our next series of
experiments showed a trend towards lower O
2
consumption
inMLC/mIGF-1 animals (Table 1). Although not significantly
different, this trend was accompanied by a significantly
higher respiratory quotient (RQ) (0.74 ± 0.02 versus 0.90 ±
0.03; 𝑃 < 0.001 WT and MLC/mIGF-1 animals, resp.)
(Table 1). According to the literature, these data strongly
suggest higher oxidation of carbohydrates [16, 17], indicating
increased utilization of carbohydrates as energy substrate in
MLC/mIGF-1 mice.
Interestingly, we did not find differences in total choles-
terol, triglycerides, or fasting glucose (Table 1). Total epi-
didymal fat, epididymal fat corrected for body weight and
percentage of body fat determined by carcass analysis also
showed no difference between WT and MLC/mIGF-1 mice
(Table 1).
Since the main metabolic difference observed between
WT andMLC/mIGF-1 animals was a preference for carbohy-
drates as energy substrate, we determined insulin sensitivity
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Figure 1: (a)Wet weight of EDL and soleus muscles fromWT (open bars) andMLC/mIGF-1 mice (filled bars). (b) Composition of each fiber
type in EDL (type I, IIa/IId and IIb) and soleus (type I, IC/IIC and IIa) muscles fromWT (open bars) andMLC/mIGF-1 mice (filled bars). (c)
Cross-sectional area-CSA (𝜇m2) of each fiber type in EDL and soleus muscles fromWT (open bars) and MLC/mIGF-1 (filled bars) mice. (d)
Serial cross-sections of the EDL and soleus muscles fromWT and MLC/mIGF-1 mice muscle were submitted to histochemistry mATPase at
pH 4.1 and 10.3. Data expressed as mean ± SEM. 𝑛 = 4-5; ∗𝑃 < 0.05 versus WT muscles.
Table 1: Biometric and metabolic parameters of wild type and MLC/mIGF-1 mice.
Wild type MLC/mIGF-1
𝑡-test
Mean SEM 𝑛 Mean SEM 𝑛
Body weight (g) 31.8 0.6 9 37.4 0.3 6 𝑃 < 0.0001
Animal length 10.2 0.05 9 10.4 0.06 6 n.s.
Daily food intake/body weight 0.21 0.007 6 0.18 0.005 6 𝑃 < 0.05
Cholesterol (mg/dL) 163 1.4 6 166 0.4 6 n.s.
Triglycerides (mg/dL) 118 3.2 6 115 5.3 5 n.s.
Glucose (mg/dL) 138 9.7 6 150 8.3 6 n.s.
Epididymal WAT (g) 0.4 0.06 9 0.5 0.05 6 n.s.
Epididymal WAT/body weight 1.2 0.2 9 1.3 0.1 6 n.s.
% body fat 4.7 0.6 5 4.0 0.6 3 n.s.
O2 consumption (mL/min/kg) 77.7 6.3 7 67.2 4.5 7 n.s.
Respiratory quotient (RQ) 0.74 0.02 7 0.90 0.03 7 𝑃 < 0.001
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Figure 2: Glucose disposal rate (a) and kITT values (b) for WT (open circles and solid line) and MLC/mIGF-1 animals (filled circles and
dotted line). Data expressed as mean ± SEM. 𝑛 = 5–7; ∗𝑃 < 0.001 versus WT.
in the animals by performing an ivITT. This test revealed
a more pronounced curve of decay in MLC/mIGF-1 mice
(Figure 2(a)). kITT determination from the ivITT showed
a 2.4%/min and 3.25%/min rate of glucose disposal in WT
and MLC/mIGF-1 animals, respectively, which represents
a 35% increase in insulin-dependent glucose disposal in
MLC/mIGF-1 mice (Figure 2(b)). The higher sensitivity to
insulin in these animals was corroborated by higher levels
of GLUT4 protein in EDL muscle (Figure 3), with ∼2-fold
upregulation in this tissue (𝑃 < 0.05) in comparisonwithWT
groups.
Since higher preference for carbohydrates was evident
in the whole animal, we decided to investigate whether key
genes involved in cell metabolism were affected in the EDL
muscle. We foundmRNA levels for PFK-1 (Phosphofructoki-
nase 1), a rate-limiting enzyme in the glycolytic pathway [20],
to be upregulated ∼3-fold in EDL muscle of MLC/mIGF-1
mice compared to WT (Figure 4(a)). We also found mRNA
for PGC1𝛼, a key regulatory element in mitochondrion
biogenesis [21], to be decreased by ∼50% in EDL muscle of
MLC/mIGF-1 mice compared to WT (Figure 4(b)).
On the other hand, fatty acid metabolism does not
appear to be disturbed in EDL muscle of MLC/mIGF-1 mice,
since the key regulatory elements, PPAR𝛽/𝛿 and PPAR𝛼 [22,
23], were unaltered in these animals in comparison to WT
(Figures 4(c) and 4(d)).
4. Discussion
In the present study we have used a genetic model in which
IGF1 is specifically expressed in fiber type II [8], allowing
a better understanding of the specific hypertrophy of those
upon metabolic profile.
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We have observed quite unique features in MLC/mIGF-1
animal model, noteworthy, MLC/mIGF-1 animals presented
relative lower food consumption despite higher muscle mass.
Curiously, they have also a shift towards higher utilization
of carbohydrate use as a fuel source, which is accompa-
nied by increased insulin sensitivity. Although we have not
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Figure 4: mRNA levels for (a) PFK-1, (b) PGC1𝛼, (c) PPAR𝛼, and (d) PPAR𝛽/𝛿 in WT (open bars) and MLC/mIGF-1 (filled bars) mice.
CycloA is an internal control. Data are expressed as mean ± SEM. 𝑛 = 3–5; ∗𝑃 < 0.05 versus WT.
specifically addressed the involved mechanisms, we reason
that the higher whole body insulin sensitivity might be due
to higher glucose uptake in type II skeletal muscle fibers,
where the IGF-1 transgene is expressed. Indeed, this selective
increased sensitivity was correlated with higher levels of
GLUT4 protein in EDL suggesting that fast twitch muscles
in IGF-1 transgenic animals have more capacity to uptake
glucose. It has been described that mIGF-1 overexpression
leads to increased activation of the PI3K/Akt/mTOR cascade
[24, 25]. Since this cascade is involved in the regulation of
GLUT4 expression, it could be a mechanism linking mIGF-
1 and GLUT4 overexpression. Future studies are needed to
better understand how GLUT4 levels are so highly elevated
in MLC/mIGF-1 animals.
A main outcome of the present study was the surprising
finding that although the MLC/mIGF-1 animals clearly have
increased muscle mass, no proportional increase in food
intake was observed. In fact these animals consume, in
absolute numbers, similar amount of food. Intriguingly, these
animals have higher insulin sensitivity and higher carbohy-
drate utilization without requiring additional food intake or
altered blood total cholesterol or triglycerides. Currently it is
not clear why and howMLC/mIGF-1 animals can build more
lean mass without more food intake. Possibilities include
BioMed Research International 7
more efficient substrate gut absorption and less energy
expenditure. A recently described myokine called irisin has
been associatedwith activation of brown fat and consequently
more energy expenditure in form of heat [26]. In addition,
it has been shown that irisin expression is increased by
PGC-1 alpha. Interestingly our results show that PGC-1
alpha expression is strongly reduced inMLC/mIGF-1 animals
as compared to WT, raising the possibility that decreased
activity of the PGC-1-irisin axis might be responsible for
sparing the necessary fuel to build increased skeletal muscle
in MLC/mIGF-1 animals.
It is currently not clear if the effects of IGF-1 increasing the
use of carbohydrates observed in the present study are direct
or rather a consequence of secondary changes in type II skele-
tal muscle fibers. It has been shown that exogenous admin-
istration of IGF1 to type 2 diabetes patients can improve
insulin sensitivity [27]; therefore, a direct effect is possible.
Another nonexclusive possibility involves secondary effects
such as type II skeletal muscle fiber hypertrophy. In fact the
MLC/mIGF1 animals have a consistent hypertrophy in those
fibers and it has been shown that increased muscle mass can
improve insulin sensitivity [28]. The metabolic consequence
of increased insulin sensitivity in the MLC/mIGF1 animals
could include resistance to the establishment of type II
diabetes. Future studies submitting mIGF-1 hyperexpression
animals to a long-term hypercaloric diet leading to increased
body weight and also crossing these animals with ob/ob mice
are warranted.
To our knowledge no studies systematically have
addressed the effects of IGF1 upon fiber type shift. In
our model we found a consistent shift in EDL towards a
glycolytic profile.This effectmight bemediated by decreasing
the levels of PGC-1. It is well described that PGC-1 is a strong
fiber type I inducer [29]. Another fiber type I inducer, the
calciuneurin-NFATc1 axis, might be modulated by IGF1
increased levels [30]. Accordingly modulation of myogenin
levels also remain as a possible mechanism since it has been
shown to shift enzyme activity from glycolytic to oxidative
metabolism [31].
Although in the present study we have, as expected,
detected hypertrophy of type II fibers (IIa/IId and IIb) in EDL
muscle, intriguingly we have also seen a decrease in cross-
sectional area in fibers IIa in soleus muscle. This unexpected
finding might reveal a conditional hypertrophic effect of
IGF1. For instance one might envisage that the fiber type
I, which is the predominant fiber in this muscle, secretes a
factor that can interfere with IGF1 hypertrophic action.
In conclusion,MLC/mIGF-1 mice have improved glucose
homeostasis due to GLUT4-mediated higher insulin sensitiv-
ity. This improvement leads to a greater rate of carbohydrate
utilization by the increased muscle, without interfering with
other metabolic parameters.
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